NCT06099327

Brief Summary

In this observational study, 100 patients admitted to the Cardiothoracic ward will be additionally monitored with video-cameras. The video-cameras will measure heart- and respiration rate continuously. Other features, such a cardiac arrhythmias and context analysis may be added as well. Data will be analysed retrospectively and will be compared with vital parameters measured with healthdot- and spot check measurements.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Feb 2024

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 12, 2023

Completed
1 month until next milestone

First Posted

Study publicly available on registry

October 25, 2023

Completed
4 months until next milestone

Study Start

First participant enrolled

February 23, 2024

Completed
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 4, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 4, 2025

Completed
Last Updated

April 11, 2025

Status Verified

April 1, 2025

Enrollment Period

12 months

First QC Date

September 12, 2023

Last Update Submit

April 9, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Percentage of signal coverage of remote, image-based monitoring in cardiac surgery patients on a general ward

    Percentage of signal loss can be due to artifacts as a result movement, lighting conditions, clinical interventions and time 'out of scope' of patients

    5-7 days

Secondary Outcomes (7)

  • The validity of remote, image-based heart- and respiration rate in comparison with heart- and respiration rate measured with the Healthdot (smart patch)

    5-7 days

  • The validity of remote, image-based monitoring of circadian rhythms in comparison with the Healthdot (smart patch)

    5-7 days

  • Discriminative ability of remote, image-based monitoring in the detection of clinical deterioration

    1 year5-7 days

  • Time to detection of clinical deterioration with the image-based monitoring technology vs conventional early warning score (measured via the spot check approach)

    5-7 days

  • Predictive value of each image-based parameter in the detection of postoperative complications

    5-7 days

  • +2 more secondary outcomes

Study Arms (1)

Postoperative after cardiac surgery

Patients after cardiac surgery will participate in the trial during their postoperative stay on the cardiothoracic ward.

Device: Image-based vital sign monitoring

Interventions

Unobtrusive, vital signs measurements with remote photoplethysmography

Postoperative after cardiac surgery

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

The intended population within this study will be cardiac surgery patients, admitted to the cardio-thoracic ward in the Catharina hospital, because they are at risk to develop postoperative complications. The research team will approach eligible patients who are scheduled to undergo cardiac surgery in collaboration with the cardio-thoracic surgeons. On average, 20 cardiac surgeries take place each week.

You may qualify if:

  • Age ≥ 18 years
  • Willing and able to sign informed consent form
  • Patients admitted to the cardio-thoracic ward postoperative after cardiac surgery
  • Planned stay on the cardio-thoracic ward at least 48 hours

You may not qualify if:

  • Pregnant patients
  • Inability to provide written informed consent
  • Mental disability
  • Language barrier
  • Inability to wear Healthdot: known severe allergy for the tissue adhesive used in the Healthdot, any skin condition or use of topicals at the area of application of the Healthdot

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Catharina ziekenhuis Eindhoven

Eindhoven, North Brabant, 5623 EJ, Netherlands

Location

MeSH Terms

Conditions

Clinical Deterioration

Condition Hierarchy (Ancestors)

Disease ProgressionDisease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Lukas Dekker, Prof. dr.

    Catharina Ziekenhuis Eindhoven

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Prof. dr.

Study Record Dates

First Submitted

September 12, 2023

First Posted

October 25, 2023

Study Start

February 23, 2024

Primary Completion

February 4, 2025

Study Completion

February 4, 2025

Last Updated

April 11, 2025

Record last verified: 2025-04

Locations